Containment of tumor-colonizing bacteria by host neutrophils

Cancer Research

Volumn 68, Issue 8, 2008, Pages 2952-2960

  Westphal, Kathrin ^a   Leschner, Sara ^a   Jablonska, Jadwiga ^a   Loessner, Holger ^a   Weiss, Siegfried ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BACTERIAL INFECTION; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; FEMALE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR IMMUNITY; TUMOR NECROSIS;

ANIMALS; BACTERIA, ANAEROBIC; CELL DIVISION; COLONIC NEOPLASMS; ESCHERICHIA COLI; FEMALE; MICE; MICE, INBRED BALB C; NECROSIS; NEUTROPHILS; SALMONELLA TYPHIMURIUM; SHIGELLA FLEXNERI;

EID: 42349102915     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-2984     Document Type: Article

References (23)

1. Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res 1991;262:3-11.
2. Van Mellaert L, Barbe S, Anne J. Clostridium spores as anti-tumour agents. Trends Microbiol 2006;14:190-6.
3. Pawelek JM, Low KB, Bermudes D. Bacteria as tumour-targeting vectors. Lancet Oncol 2003;4:548-56.
4. Bermudes D, Zheng LM, King IC. Live bacteria as anticancer agents and tumor-selective protein delivery vectors. Curr Opin Drug Discov Devel 2002;5:194-9.
5. Michl P, Gress TM. Bacteria and bacterial toxins as therapeutic agents for solid tumors. Curr Cancer Drug Targets 2004;4:689-702.
6. Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B. Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A 2001;98:15155-60.
7. Sznol M, Lin SL, Bermudes D, Zheng LM, King I. Use of preferentially replicating bacteria for the treatment of cancer. J Clin Invest 2000;105:1027-30.
8. Jain RK, Forbes NS. Can engineered bacteria help control cancer? Proc Natl Acad Sci U S A 2001;98:14748-50.
9. Theys J, Barbe S, Landuyt W, et al. Tumor-specific gene delivery using genetically engineered bacteria. Curr Gene Ther 2003;3:207-21.
10. Fujimori M. Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. Breast Cancer 2006;13:27-31.
11. Bettegowda C, Dang LH, Abrams R, et al. Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria. Proc Natl Acad Sci U S A 2003;100:15083-8.
12. Zhao M, Yang M, Li XM, et al. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci U S A 2005;102:755-60.
13. Zhao M, Yang M, Ma H, et al. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 2006;66:7647-52.
14. Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci U S A 2007;104:10170-4.
15. Saltzman DA. Cancer immunotherapy based on the killing of Salmonella typhimurium-infected tumour cells. Expert Opin Biol Ther 2005;5:443-9.
16. Forbes NS, Munn LL, Fukumura D, Jain RK. Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. Cancer Res 2003;63:5188-93.
17. Yu YA, Shabahang S, Timiryasova TM, et al. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 2004;22:313-20.
18. Lee CH, Wu CL, Tai YS, Shiau AL. Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy. Mol Ther 2005;11:707-16.
19. Agrawal N, Bettegowda C, Cheong I, et al. Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A 2004;101:15172-7.
20. Hoiseth, SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981;291:238-9.
21. Sansonetti PJ, Kopecko DJ, Formal SB. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immunol 1982;35:852-60.
22. Lardner A. The effects of extracellular pH on immune function. J Leukoc Biol 2001;69:522-30.
23. Loessner H, Endmann A, Leschner S, et al. Remote control of tumour-targeted Salmonella enterica serovar typhimurium by the use of l-arabinose as inducer of bacterial gene expression in vivo. Cell Microbiol 2007;9:1529-37.